Latest:
Dr Gehrig on the Use of Genetic Testing in Endometrial Cancer
Paola Gehrig, MD, discusses the optimal use and timing of genetic testing in endometrial cancer.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Mayur Narkhede, MD
Latest:
Dr. Narkhede on Siltuximab for CRS and ICANS in Hematologic Malignancies
Mayur Narkhede, MD, discusses findings from a pre-planned interim analysis of a phase 2 trial investigating siltuximab for the treatment of cytokine release syndrome and immune effector cell–associated neurotoxicity syndrome related to CAR T-cell therapy in adult patients with hematologic malignancies.
Richard J. Lin, MD, PhD
Latest:
Dr. Lin on Second-line CAR T-cell Therapy in Relapsed/Refractory DLBCL
Richard J. Lin, MD, PhD, discusses the manufacturing considerations that factor into the CAR T-cell decision-making process in diffuse large B-cell lymphoma, the importance of open communication between community and referral physicians, and how early referral leads to optimal patient outcomes with CAR T-cell therapy.
Rodney Pommier, MD
Latest:
Advice for Community Physicians Treating Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome
Drs Das, Pommier, and Zacks share their advice for community physicians treating patients who have neuroendocrine tumors with carcinoid syndrome and carcinoid heart disease.
Douglas Flora, MD, LSSBB, FACCC
Latest:
Assessing the Promise of AI in Oncology: Looking to the Future
In this final episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss a roadmap of artificial intelligence (AI) advances in the next 5 to 10 years.
Vivek G Patel, MD
Vivek G Patel, MD, is an assistant professor of medicine in the Division of Hematology Oncology at Vanderbilt University Medical Center.
Latest:
Dr Patel on Ongoing Research With Subcutaneous Bispecific Antibodies in Frontline Follicular Lymphoma
Vivek G. Patel, MD, discusses the potential advantages of subcutaneous bispecific antibodies that are being evaluated in frontline follicular lymphoma.
Renee Kurz, DNP, FNP-BC, AOCNP
Latest:
Dr Kurz on Social Determinants of Health That Contribute to Disparities in Cancer Care
Renee Kurz, DNP, FNP-BC, AOCNP, discusses social determinants of health that can contribute to disparities in cancer care, highlighting examples seen throughout New Jersey that emphasize the need for further investigation into this landscape.
Jia Luo, MD
Jia Luo, MD, is a physician at Dana-Farber Cancer Institute and an instructor in Medicine at Harvard Medical School, both in Boston, Massachusetts.
Latest:
Dr Luo on the Association Between ctDNA and Response to Daraxonrasib in RAS G12X–Mutant Advanced NSCLC
Jia Luo, MD, discusses ctDNA outcomes following treatment of daraxonrasib in ctDNA-evaluable patients with RAS G12X–mutant advanced NSCLC.